This video features Sanofi, Bristol-Myers Squibb, and Teva. Max Macaluso has no position in any stocks mentioned, and neither does The Motley Fool.
Three dividend-paying pharmaceutical stocks -- Sanofi (SNY 2.00%), Bristol-Myers Squibb (BMY 1.30%), and Teva (TEVA 0.63%) -- have earned the much-coveted five-star rating from The Motley Fool CAPS community. However, are all of these stocks well positioned for growth? Are Sanofi and Bristol-Myers Squibb's top lines still hurting from patent expirations? Does Teva have significant challenges ahead? Analyst Max Macaluso offers his opinion on these three stocks in the following video.
The wisdom of Warren Buffett
